Teri Brentnall, MD
Dr. Brentnall is a clinical gastroenterologist who also is a cancer researcher. In the clinical realm, she specializes in caring for patients that have an elevated risk of intestinal cancer due to hereditary susceptibility. This includes hereditary colon cancer, pancreatic cancer, stomach cancer to name a few. She is the co-director of the Pancreatic Cancer Surveillance program at the UWMC, along with Dr. Michael Saunders. This is an endoscopic surveillance program for patients who have multiple family members with pancreatic cancer or for patients who have a known gene mutation that predisposes them to pancreatic cancer.
On the research side, Dr. Brentnall is working on the earlier detection of pancreatic cancer and IBD-related colon cancer through the development of cancer biomarkers and molecular imaging.